209 related articles for article (PubMed ID: 29931438)
1. [Genetics of thyroid nodules and thyroid carcinoma].
Führer D
Internist (Berl); 2018 Jul; 59(7):674-680. PubMed ID: 29931438
[TBL] [Abstract][Full Text] [Related]
2. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative molecular testing on fine-needle aspiration in precision management of thyroid cancer].
Song YT; Zhang B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):58-61. PubMed ID: 30704174
[TBL] [Abstract][Full Text] [Related]
4. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
5. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
6. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
Daniels GH
Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
[No Abstract] [Full Text] [Related]
7. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
8. Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics.
Yim JH; Choi AH; Li AX; Qin H; Chang S; Tong ST; Chu P; Kim BW; Schmolze D; Lew R; Ibrahim Y; Poroyko VA; Salvatierra S; Baker A; Wang J; Wu X; Pfeifer GP; Fong Y; Hahn MA
Clin Cancer Res; 2019 Jan; 25(2):544-551. PubMed ID: 30093451
[TBL] [Abstract][Full Text] [Related]
9. Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy.
Sorrenti S; Baldini E; Tartaglia F; Catania A; Arcieri S; Pironi D; Calò PG; Filippini A; Ulisse S
Aging Clin Exp Res; 2017 Feb; 29(Suppl 1):7-13. PubMed ID: 27832468
[TBL] [Abstract][Full Text] [Related]
10. [Molecular Pathogenesis of Thyroid Nodules: Relevance for Clinical Care].
Führer D; Musholt T; Schmid KW
Laryngorhinootologie; 2017 Sep; 96(9):590-596. PubMed ID: 28881369
[TBL] [Abstract][Full Text] [Related]
11. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
Cantara S; Capezzone M; Marchisotta S; Capuano S; Busonero G; Toti P; Di Santo A; Caruso G; Carli AF; Brilli L; Montanaro A; Pacini F
J Clin Endocrinol Metab; 2010 Mar; 95(3):1365-9. PubMed ID: 20130073
[TBL] [Abstract][Full Text] [Related]
12. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.
Kang G; Cho EY; Shin JH; Chung JH; Kim JW; Oh YL
Cancer Cytopathol; 2012 Feb; 120(1):44-51. PubMed ID: 21751431
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
[TBL] [Abstract][Full Text] [Related]
15. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.
Karunamurthy A; Panebianco F; J Hsiao S; Vorhauer J; Nikiforova MN; Chiosea S; Nikiforov YE
Endocr Relat Cancer; 2016 Apr; 23(4):295-301. PubMed ID: 26911375
[TBL] [Abstract][Full Text] [Related]
17. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
[TBL] [Abstract][Full Text] [Related]
18. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
[TBL] [Abstract][Full Text] [Related]
19. Search for genetic mutations in cytological samples from thyroid nodules as a diagnostic tool: reality, hope or myth?
Pacini F; Cantara S; Capezzone M
J Endocrinol Invest; 2010 Sep; 33(8):576-8. PubMed ID: 20930496
[No Abstract] [Full Text] [Related]
20. The molecular diagnosis and management of thyroid neoplasms.
Theoharis C; Roman S; Sosa JA
Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
